Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant

Hepatic veno-occlusive disease or sinusoidal obstructive syndrome (VOD/SOS) is a life-threatening complication of hematopoietic stem cell transplantation (HSCT). Defibrotide is the only medication approved by the US Food and Drug Administration for the management of severe VOD/SOS after HSCT. We rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Nauffal, Mary, Kim, Haesook T., Richardson, Paul G., Soiffer, Robert J., Antin, Joseph H., Cutler, Corey, Nikiforow, Sarah, Gooptu, Mahasweta, Koreth, John, Romee, Rizwan, Ho, Vincent T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753224/
https://www.ncbi.nlm.nih.gov/pubmed/34666352
http://dx.doi.org/10.1182/bloodadvances.2021005410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753224/
https://www.ncbi.nlm.nih.gov/pubmed/34666352
http://dx.doi.org/10.1182/bloodadvances.2021005410

Ejemplares similares